VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $1,318,000 | -69.2% | 12,969 | -46.0% | 0.35% | -72.1% |
Q3 2015 | $4,286,000 | -24.0% | 24,025 | -5.4% | 1.25% | -15.4% |
Q2 2015 | $5,643,000 | +27.4% | 25,404 | +13.9% | 1.48% | +24.8% |
Q1 2015 | $4,429,000 | +19.3% | 22,301 | -14.0% | 1.18% | +19.7% |
Q4 2014 | $3,711,000 | – | 25,934 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |